A new wave of middlemen offers ‘alternative funding’ for specialty drugs. Patients bear the risks – Fierce Healthcare

A new wave of middlemen offers ‘alternative funding’ for specialty drugs. Patients bear the risks  Fierce Healthcare

>View original article
Contributor: